Radiolabelled Tracers and Anticancer Drugs for Assessment of Therapeutic Efficacy Using PET

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|7|18|1863-1892

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.18, 2001-12, pp. : 1863-1892

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Individualized Treatment Planning in Oncology: Role of PET and Radiolabelled Anticancer Drugs in Predicting Tumour Resistance

By  

Current Pharmaceutical Design, Vol. 14, Iss. 28, 2008-10 ,pp. : 2914-2931

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacodynamics of Radiolabelled Anticancer Drugs for Positron Emission Tomography

By  

Current Pharmaceutical Design, Vol. 9, Iss. 11, 2003-04 ,pp. : 931-944

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics of Radiolabelled Anticancer Drugs for Positron Emission Tomography

By  

Current Pharmaceutical Design, Vol. 9, Iss. 11, 2003-04 ,pp. : 917-929

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Fluorine-Containing Drugs as PET Diagnostics (F-18 Labeled Tracers)]

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 8, 2013-04 ,pp. : 869-870

Bentham Science Publishers

Access to resources Recommend Favorite

Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs

By Sai Kimie   Saito Yoshiro  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 8, 2011-08 ,pp. : 967-988

Informa Healthcare

Access to resources Recommend Favorite